China
· Delayed Price · Currency is CNY Jafron Biomedical Statistics
Total Valuation
SHE:300529 has a market cap or net worth of CNY 16.70 billion. The enterprise value is 15.53 billion.
| Market Cap | 16.70B |
| Enterprise Value | 15.53B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | May 26, 2025 |
Share Statistics
SHE:300529 has 774.36 million shares outstanding. The number of shares has decreased by -1.94% in one year.
| Current Share Class | 774.36M |
| Shares Outstanding | 774.36M |
| Shares Change (YoY) | -1.94% |
| Shares Change (QoQ) | +12.28% |
| Owned by Insiders (%) | 50.98% |
| Owned by Institutions (%) | 15.27% |
| Float | 374.23M |
Valuation Ratios
The trailing PE ratio is 23.27 and the forward PE ratio is 17.30.
| PE Ratio | 23.27 |
| Forward PE | 17.30 |
| PS Ratio | 6.73 |
| PB Ratio | 4.73 |
| P/TBV Ratio | 4.87 |
| P/FCF Ratio | 26.89 |
| P/OCF Ratio | 20.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.28, with an EV/FCF ratio of 24.99.
| EV / Earnings | 21.44 |
| EV / Sales | 6.26 |
| EV / EBITDA | 15.28 |
| EV / EBIT | 17.57 |
| EV / FCF | 24.99 |
Financial Position
The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.40.
| Current Ratio | 3.94 |
| Quick Ratio | 3.42 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 1.39 |
| Debt / FCF | 2.27 |
| Interest Coverage | 14.34 |
Financial Efficiency
Return on equity (ROE) is 21.24% and return on invested capital (ROIC) is 11.07%.
| Return on Equity (ROE) | 21.24% |
| Return on Assets (ROA) | 9.57% |
| Return on Invested Capital (ROIC) | 11.07% |
| Return on Capital Employed (ROCE) | 18.02% |
| Revenue Per Employee | 886,957 |
| Profits Per Employee | 258,925 |
| Employee Count | 2,797 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.40 |
Taxes
In the past 12 months, SHE:300529 has paid 173.72 million in taxes.
| Income Tax | 173.72M |
| Effective Tax Rate | 19.47% |
Stock Price Statistics
The stock price has decreased by -20.69% in the last 52 weeks. The beta is 0.46, so SHE:300529's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -20.69% |
| 50-Day Moving Average | 21.73 |
| 200-Day Moving Average | 26.65 |
| Relative Strength Index (RSI) | 50.30 |
| Average Volume (20 Days) | 4,791,391 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300529 had revenue of CNY 2.48 billion and earned 724.21 million in profits. Earnings per share was 0.93.
| Revenue | 2.48B |
| Gross Profit | 2.01B |
| Operating Income | 883.48M |
| Pretax Income | 892.16M |
| Net Income | 724.21M |
| EBITDA | 1.01B |
| EBIT | 883.48M |
| Earnings Per Share (EPS) | 0.93 |
Balance Sheet
The company has 2.59 billion in cash and 1.41 billion in debt, giving a net cash position of 1.18 billion or 1.52 per share.
| Cash & Cash Equivalents | 2.59B |
| Total Debt | 1.41B |
| Net Cash | 1.18B |
| Net Cash Per Share | 1.52 |
| Equity (Book Value) | 3.53B |
| Book Value Per Share | 4.56 |
| Working Capital | 2.29B |
Cash Flow
In the last 12 months, operating cash flow was 812.95 million and capital expenditures -191.71 million, giving a free cash flow of 621.24 million.
| Operating Cash Flow | 812.95M |
| Capital Expenditures | -191.71M |
| Free Cash Flow | 621.24M |
| FCF Per Share | 0.80 |
Margins
Gross margin is 81.17%, with operating and profit margins of 35.61% and 29.19%.
| Gross Margin | 81.17% |
| Operating Margin | 35.61% |
| Pretax Margin | 35.96% |
| Profit Margin | 29.19% |
| EBITDA Margin | 40.83% |
| EBIT Margin | 35.61% |
| FCF Margin | 25.04% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 3.76%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 3.76% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 46.39% |
| Buyback Yield | 1.94% |
| Shareholder Yield | 5.70% |
| Earnings Yield | 4.34% |
| FCF Yield | 3.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 20, 2020. It was a forward split with a ratio of 1.9.
| Last Split Date | May 20, 2020 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
SHE:300529 has an Altman Z-Score of 8.2 and a Piotroski F-Score of 8.
| Altman Z-Score | 8.2 |
| Piotroski F-Score | 8 |